Pages that link to "Q22241283"
Jump to navigation
Jump to search
The following pages link to Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes (Q22241283):
Displaying 50 items.
- Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration (Q22241965) (← links)
- Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle (Q22241966) (← links)
- Molecular mechanism of action of metformin: old or new insights? (Q22252798) (← links)
- The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes (Q22306221) (← links)
- Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation (Q24535576) (← links)
- Metformin revisited: Does this regulator of AMP-activated protein kinase secondarily affect bone metabolism and prevent diabetic osteopathy (Q26750278) (← links)
- Pancreatic regulation of glucose homeostasis (Q26766485) (← links)
- General aspects of muscle glucose uptake (Q26991925) (← links)
- Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium (Q26999344) (← links)
- Mitochondrial biogenesis: regulation by endogenous gases during inflammation and organ stress (Q27025057) (← links)
- Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs (Q28246959) (← links)
- Two weeks of metformin treatment enhances mitochondrial respiration in skeletal muscle of AMPK kinase dead but not wild type mice (Q28485110) (← links)
- Xanthene derivatives increase glucose utilization through activation of LKB1-dependent AMP-activated protein kinase (Q28543206) (← links)
- Novel Approach to Identify Potential Bioactive Plant Metabolites: Pharmacological and Metabolomics Analyses of Ethanol and Hot Water Extracts of Several Canadian Medicinal Plants of the Cree of Eeyou Istchee (Q28547147) (← links)
- Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells (Q28550634) (← links)
- Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons (Q28553200) (← links)
- Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia (Q28581219) (← links)
- AMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscle (Q28592195) (← links)
- The metabolic consequences of hepatic AMP-kinase phosphorylation in rainbow trout (Q28744383) (← links)
- AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha (Q29620443) (← links)
- Atypical PKC: a target for treating insulin-resistant disorders of obesity, the metabolic syndrome and type 2 diabetes mellitus. (Q30366716) (← links)
- Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3. (Q33251776) (← links)
- Gain-of-function R225W mutation in human AMPKgamma(3) causing increased glycogen and decreased triglyceride in skeletal muscle (Q33299468) (← links)
- Effect of the combination of mitiglinide and metformin on glycemic control in patients with type 2 diabetes mellitus (Q33558365) (← links)
- Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study (Q33569099) (← links)
- Arctigenin alleviates ER stress via activating AMPK. (Q33570821) (← links)
- AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC. (Q33655490) (← links)
- AMPK activation--protean potential for boosting healthspan (Q33689169) (← links)
- Metformin combined with acarbose vs. single medicine in the treatment of type 2 diabetes: A meta-analysis (Q33744996) (← links)
- Influence of Plantago ovata husk (dietary fiber) on the bioavailability and other pharmacokinetic parameters of metformin in diabetic rabbits (Q33776193) (← links)
- Decreased plasma nesfatin-1 level is related to the thyroid dysfunction in patients with type 2 diabetes mellitus. (Q33786737) (← links)
- The Stimulatory Effect of Essential Fatty Acids on Glucose Uptake Involves Both Akt and AMPK Activation in C2C12 Skeletal Muscle Cells (Q33807582) (← links)
- Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells. (Q33821960) (← links)
- AMP-activated protein kinase (AMPK)α2 plays a role in determining the cellular fate of glucose in insulin-resistant mouse skeletal muscle (Q33822976) (← links)
- alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice (Q33900969) (← links)
- Oxidative stress stimulates skeletal muscle glucose uptake through a phosphatidylinositol 3-kinase-dependent pathway (Q33901770) (← links)
- A link between hepatic glucose production and peripheral energy metabolism via hepatokines (Q33906438) (← links)
- LKB1 and AMPK and the regulation of skeletal muscle metabolism (Q33919567) (← links)
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state (Q33968008) (← links)
- Targeted therapies of the LKB1/AMPK pathway for the treatment of insulin resistance (Q34004470) (← links)
- Molecular insights and therapeutic targets for diabetic endothelial dysfunction (Q34022332) (← links)
- Effects of exercise training on mitochondrial function in patients with type 2 diabetes. (Q34023559) (← links)
- Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats (Q34065151) (← links)
- Metformin inhibits food intake and neuropeptide Y gene expression in the hypothalamus (Q34095221) (← links)
- Optimising the medical management of hyperglycaemia in type 2 diabetes in the Middle East: pivotal role of metformin (Q34113354) (← links)
- AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK (Q34132234) (← links)
- Metformin inhibits P‐glycoprotein expression via the NF‐κB pathway and CRE transcriptional activity through AMPK activation (Q34148357) (← links)
- The effect of metformin treatment in vivo on acute and long-term energy metabolism and progesterone production in vitro by granulosa cells from women with polycystic ovary syndrome (Q34181502) (← links)
- AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes (Q34268235) (← links)
- Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin (Q34292557) (← links)